WIXOM, Mich., Oct. 25 /PRNewswire-FirstCall/ -- Rockwell Medical Technologies, Inc. (Nasdaq: RMTI - News), a leading, innovative manufacturer and developer of concentrates and specialty pharmaceuticals focused on the end-stage-renal-disease market (ESRD), reported today that it has received notice from the Canadian Patent Office that its application for its Dri- Sate® Dry Acid Concentrate Mix System has been allowed.
